about
Dietary approach in the treatment of nonalcoholic fatty liver diseaseInteraction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infectionBeneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.The central role of the gut microbiota in chronic inflammatory diseases.Skin wound healing is accelerated and scarless in the absence of commensal microbiota.A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout.Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice.Microbiota is an essential element for mice to initiate a protective immunity against Vaccinia virus.The absence of microbiota delays the inflammatory response to Cryptococcus gattii.Evaluation of Potential Probiotics Isolated from Human Milk and Colostrum.Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection.The role of probiotics and prebiotics in inducing gut immunity.Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?Evaluation of colonisation resistance in stool of human donors using ex vivo, in vitro and in vivo assays.Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice.Dietary glutamine prevents the loss of intestinal barrier function and attenuates the increase in core body temperature induced by acute heat exposure.L-arginine supplementation prevents increases in intestinal permeability and bacterial translocation in male Swiss mice subjected to physical exercise under environmental heat stress.Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice.Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease.Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A).Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.Prophylactic Supplementation of Bifidobacterium longum 51A Protects Mice from Ovariectomy-Induced Exacerbated Allergic Airway Inflammation and Airway HyperresponsivenessInfluence of indigenous microbiota on experimental toxoplasmosis in conventional and germ-free mice.The role of L-arginine-nitric oxide pathway in bacterial translocation.Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change?Oral administration of Saccharomyces cerevisiae UFMG A-905 prevents allergic asthma in mice.Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model.The cytosolic sensor STING is required for intestinal homeostasis and control of inflammation.Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics.Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp. enterica serovar Typhimurium in mice.Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice.The Metabolic Sensor GPR43 Receptor Plays a Role in the Control of Klebsiella pneumoniae Infection in the Lung.Effect of Conjugated Linoleic Acid-enriched Butter After 24 hours of Intestinal Mucositis Induction.Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardiiOral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of goutTreatment with Selemax®, a selenium-enriched yeast, ameliorates experimental arthritis in rats and miceComparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic propertiesProphylactic Bifidobacterium adolescentis ATTCC 15703 supplementation reduces partially allergic airway disease in Balb/c but not in C57BL/6 mice
P50
Q26777508-589B35F4-2AE0-473E-8C12-EF367F9D5B39Q28472674-EEE40107-4CB9-4C11-9FF1-9E85F36AB88CQ30377409-3615F28D-E52F-43B0-8C74-70596C87DCADQ34305760-A7A7B520-C9D4-4B6F-81CD-C52E761C0877Q35344485-0717EAE4-862F-4AD8-B0C8-70E1F0635100Q35614971-C576B352-11F8-4032-88B7-514BFD519E36Q35725360-7FF41FF6-58BD-4E5F-92AE-73AD0B76A9E4Q35853679-DD0C660A-95FF-403E-9BF4-295D159C9A7FQ35991261-A67DD75E-5743-40DC-96DA-0FD8C2622CFEQ36333415-B260F48A-03DE-4E7F-83C5-4A16C46E6DFBQ37488090-68F4B8BF-644A-41C6-8930-C818CF509B81Q38174603-AEDE0BA6-D4AE-425C-B143-6DDDA45CC696Q38542708-614A6078-0183-4E90-8B42-C7075CD70E84Q39002707-26756618-7921-4D83-9379-5AEF7F6918D9Q39219877-0BC789B5-B1FD-44F0-9818-CD7C1A94B79AQ40186587-5A67502E-6B6B-4FF2-8A67-054CFEAD9C4EQ40227507-B46598C5-85FC-47D9-AF80-EC5E2E710C2FQ40258638-840DC274-7C2D-492C-92CB-147AFF41121AQ40591128-D3ABD995-2C57-4145-A7EB-568EBCB369ACQ40918154-79C8E04D-D652-4F1B-9EF7-58824C763155Q40982304-979A7B24-4CCB-471C-A6D7-22D279521A3AQ41673191-F787F5E7-D168-427C-A6D1-52EB56EF57F9Q43168806-ED930726-3B90-48DF-A328-91BF5D5DD8C6Q45146307-AAC81B25-8677-4D5A-A2FE-99878C4A46A7Q46575772-88CD0D17-4B4A-44A2-87C0-4281BF96A118Q47980747-7769E434-1FC4-4BC6-9B41-1FD2855E4EEDQ49837438-F52D700A-9FAA-4005-A6AB-5F6245DB6D4EQ49925661-561BF83F-4FCF-4BB0-BD26-EA8CBB784F22Q50026885-404F886A-CCF5-4FBE-AF59-403CF1EF39BDQ50052944-1B4FC677-50D4-4236-B091-C0E24D0B7B37Q51035866-EA36CF42-4479-4390-AA78-E6AA848FED10Q51590511-5600D409-A32D-4391-B601-DCC4EB7195D1Q51743237-E4D8D386-3A40-401E-ABA1-517D10C6B094Q53020267-2BACDE85-801F-4551-9799-F380C0A7F0B2Q53110571-D1216AE8-6BDD-4E98-9621-E14C45B69CC0Q57121182-F22E4DB2-6C50-4EF9-852A-306625AF0378Q58227565-D42D8D5C-710B-45D6-8B70-C7D0C1EDBAF4Q58227580-73A6F9F2-19BE-49FD-A25F-3D21C7499F92Q58227598-F50BFC83-9217-4347-8066-8E0DB77F0C7AQ62555760-3B2CC262-2E42-4E9C-9D9C-AFCDDF6BEE82
P50
description
researcher ORCID ID = 0000-0003-0741-3062
@en
wetenschapper
@nl
name
Flaviano S Martins
@ast
Flaviano S Martins
@en
Flaviano S Martins
@es
Flaviano S Martins
@nl
type
label
Flaviano S Martins
@ast
Flaviano S Martins
@en
Flaviano S Martins
@es
Flaviano S Martins
@nl
prefLabel
Flaviano S Martins
@ast
Flaviano S Martins
@en
Flaviano S Martins
@es
Flaviano S Martins
@nl
P1153
16028783200
P31
P496
0000-0003-0741-3062